JROSG−Japanese Radiation Oncology Study Group−

臨床放射線腫瘍学

最新知見に基づいた放射線治療の実践　オンラインアクセス権付

Ishibashi N, Ejima Y, Soejima T, Kawaguchi H, Taguchi S, Ito H, Shimizuguchi T, Isobe K, Hasegawa M, Sasai K, Imai M, Shimoda E, Kaizu H, Okano N, Imagumbai T, Akimoto T.Autologous Peripheral Blood Stem Cell Transplantation and Timing of Local Radiation Therapy in Patients with Malignant Lymphoma: Results of the Japanese Radiation Oncology Study Group Questionnaire Survey.Anticancer Res. 2024 Jul;44(7):3033-3041.

若月 優, 安藤 謙, 小此木範之, 兼安祐子, 生島仁史, 加藤眞吾, 大野達也。子宮頸癌IGBTにおける子宮体部・腟側に対する線量評価に関するアンケート調査。日本放射線科専門医会・医会学術雑誌. 2024; 4: 31-35.

Sekii S, Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, Mitsuhashi N, Yamada K, Takahashi T, Ito K, Kawamoto T, Araki N, Nozaki M, Heianna J, Murotani K, Hirano Y, Satoh A, Onoe T, Shikama N.Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3).Clin Transl Radiat Oncol. 2023 Jul 3;42:100657.

Kawamoto T, Shikama N, Imano N, Kubota H, Kosugi T, Sekii S, Harada H, Yamada K, Naoi Y, Miyazawa K, Hirano Y, Wada Y, Tonari A, Saito T, Uchida N, Araki N, Nakamura N.Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study.Breast Cancer. 2023 Mar;30(2):282-292.

Murofushi KN, Itasaka S, Shimokawa M, Murakami Y, Yamamoto T, Nishimura Y, Kudo S, Sakamoto T, Ariga T, Ogo E, Taguchi K, Jingu K, Ogawa K.A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial).J Radiat Res. 2023 Jan 20;64(1):154-161

Kawamoto T, Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, Mitsuhashi N, Yamada K, Takahashi T, Ito K, Sekii S, Araki N, Nozaki M, Heianna J, Murotani K, Hirano Y, Satoh A, Onoe T, Shikama N.Temporal Profiles of Symptom Scores After Palliative Radiotherapy for Bleeding Gastric Cancer With Adjustment for the Palliative Prognostic Index: An Exploratory Analysis of a Multicentre Prospective Observational Study (JROSG 17-3).Clin Oncol (R Coll Radiol). 2022 Dec;34(12):e505-e514.

Ota Yet al.Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2).Int J Clin Oncol. 27(11):1675-1683, 2022

Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, Mitsuhashi N, Yamada K, Takahashi T, Ito K, Sekii S, Araki N, Nozaki M, Heianna J, Murotani K, Hirano Y, Satoh A, Onoe T, Watakabe T, Shikama N.Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3).Gastric Cancer. 2022 Mar;25(2):411-421.

Ikushima H, Haga A, Ando K, Kato S, Kaneyasu Y, Uno T, Okonogi N, Yoshida K, Ariga T, Isohashi F, Harima Y, Kanemoto A, Ii N, Wakatsuki M, Ohno T.Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging.radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.J Radiat Res. 2022;63(1):98-106.

Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K; Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) Investigators.Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.Clin Transl Radiat Oncol 27(37)：116-129, 2022

Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, Uno T, Tokumaru S, Harima Y, Gomi H, Toita T, Kita M, Noda SE, Takahashi T, Kato S, Ohkawa A, Tozawa-Ono A, Ushijima H, Hasumi Y, Hirashima Y, Niibe Y, Nakagawa T, Akita T, Tanaka J, Ohno T; Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.J Radiat Res. 2021;62(2):269-284.

Kawamoto T, Nakamura N, Saito T, Tonari A, Wada H, Harada H, Kubota H, Nagakura H, Heianna J, Miyazawa K, Yamada K, Tago M, Fushiki M, Nozaki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Shikama N.Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.Jpn J Clin Oncol. 2021 May 28;51(6):950-955.

Harima Y, Ariga T, Kaneyasu Y, Ikushima H, Tokumaru S, Shimamoto S, Takahashi T, Ii N, Tsujino K, Saito AI, Ushijima H, Toita T, Ohno T. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.PLoS One. 2021;16(11):e0259235.

Yokota T et a.Real‑world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12‑2).Int J Clin Oncol.26:316-325,2021

Kubota H, Nakamura N, Shikama N, Tonari A, Wada H, Harada H, Nagakura H, Heianna J, Ito K, Nozaki M, Tago M, Fushiki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Kawamoto T, Saito T, Yamada K. Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group. J Radiat Res. 2021 Mar 10;62(2):356-363. doi: 10.1093/jrr/rraa133. PMID: 33454759.

Harada H, Shikama N, Wada H, Uchida N, Nozaki M, Hayakawa K, Yamada K, Nagakura H, Ogawa H, Miyazawa K, Katagiri H, Nakamura N. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma. Jpn J Clin Oncol. 2021 Jan 1;51(1):100-105.

Yasuhito Hagiwara, YukoNakayama, Shigehiro Kudo, ToyokazuHayakawa, Naoki Nakamura, Yoshizumi Kitamoto, Shigeo Takahashi, Kayoko Tsujino, Nobuteru Kubo, Yukihisa Tamaki, Yasushi Nagata and The Japan Radiation Oncology Study Group (JROSG) Working Subgroup for Lung and MediastinalTumors Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease. Journal of Radiation Research 2020 May 4;rraa018. doi: 10.1093/jrr/rraa018. Online ahead of print.

Murakami Y, Kenjo M, Ishikawa K, Sakayauchi T, Itasaka S, Negoro Y, Jingu K, Nishimura Y, Nagata Y, Ogawa K.Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents. J Radiat Res. 2020 Jul 6;61(4):629-634.

Hiroki Kawaguchi, Toshinori Soejima, Naoya Ishibashi, Takeshi Akiba, Masatoshi Hasegawa, Kouichi Isobe, Hitoshi Ito, Michiko Imai, Yasuo Ejima, Masaharu Hata, Keisuke Sasai, Emiko Shimoda, Masahiko Oguchi and Tetsuo Akimoto, on behalf of the Japanese Radiation Oncology Study Group. National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group. Journal of Radiation Research, Vol. 60, No. 5, 2019, pp. 579–585 doi: 10.1093

太田 陽介, 古平 毅, 藤井 博文, 下川 元継, 中島 寅彦, 門田 伸也, 横田 知哉, 本間 明宏, 上田 眞也, 秋元 哲夫,日本人の頭頸部扁平上皮癌患者に対するCetuximab併用放射線治療の観察研究（JROSG12-2）－有害事象に関する中間評価－,頭頸部癌 2019年45巻3号 p. 330-336

Jingu K, Takahashi N, Murakami Y, Ishikawa K, Itasaka S, Takahashi T, Isohashi F, Sakayauchi T, Ogawa K; JROSG Working Subgroup of Gastrointestinal Cancers.Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?Anticancer Res. 2019 Aug;39(8):4279-4283.

Akamatsu H, Nakamura K, Ebara T, Inaba K, Itasaka S, Jingu K, Kosaka Y, Murai T, Nagata K, Soejima T, Takahashi S, Toyoda T, Toyoshima S, Nemoto K, Akimoto T.　Organ-preserving approach via radiotherapy for small-cell carcinoma of the bladder: An analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey. J Radiat Res. 2019 Jul 1;60(4):509-516. doi: 10.1093/jrr/rrz018.

Hiroko Akamatsu, Katsumasa Nakamura, Takeshi Ebara, Koji Inaba, Satoshi Itasaka, Keiichi Jingu, Yasuhiro Kosaka, Taro Murai, Kenji Nagata, Toshinori Soejima, Shigeo Takanashi, Tatsuya Toyoda, Shinichiro Toyoshima, Kenji Nemoto and Tetsuo Akimoto. Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey. Journal of Radiation Research, Vol. 60, No. 4, 2019, pp. 509-516 doi: 10.1093

Norihiro Aibe, Kumiko Karasawa, Masahiko Aoki, Keiko Akahane, Yasuhiro Ogawa, Etsuyo Ogo, Shuichi Kanamori, Jiro Kawamori, Anneyuko I Saito, Kenshiro Shiraishi, Hiroshi Sekine, Seiji Tachiiri, Michio Yoshimura, Chikako Yamauchi Results of a Nationwide Survey on Japanese Clinical Practice in Breast-Conserving Radiotherapy for Breast Cancer. J Radiat Res. 2019 Jan 1;60(1): 142-149. doi: 10.1093/jrr/rry095.

Naoya Ishibashi, Toshinori Soejima, Hiroki Kawaguchi, Takeshi Akiba, Masatoshi Hasegawa, Kouichi Isobe, Hitoshi Ito, Michiko Imai, Yasuo Ejima, Masaharu Hata, Keisuke Sasai, Emiko Shimoda, Toshiya Maebayashi, Masahiko Oguchi and Tetsuo Akimoto, on behalf of the Japanese Radiation Oncology Study Group. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). Journal of Radiation Research, Vol. 59, No. 4, 2018, pp. 477–483 doi: 10.1093/jrr/rry017

Harada, K., Igaki, H., Abe, E., Ariga, T., Hayashi, N., Kanemoto, A., Komiyama, T., Matsumoto, Y., Nakano, T., Onimaru, R., Saito, H., Sumi, M., Tago, M., Tanaka, K., Maebayashi, K., Aoyama, H., & Japanese Radiation Oncology Study Group (JROSG) Working Subgroup for Neurological Tumors (2018). Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors. International journal of clinical oncology, 23(6), 1015–1022. https://doi.org/10.1007/s10147-018-1313-4

兼安祐子、藤原久也、西村哲夫、加藤真吾、大野達也、櫻井英幸、楮本智子、生島仁史、宇野隆、徳丸直郎、播磨洋子、五味弘道、喜多みどり、野田真永、高橋健夫、新部譲、戸板孝文。子宮頸癌に対する日本語版QOL調査票の開発。日本婦人科腫瘍学会誌, 2018: 36: 682-691

Ikushima H, Wakatsuki M, Ariga T, aneyasu Y, Tokumaru S, Isohashi F, Ii N, Uno T, Ohno T, Arisawa K, Toita T. Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group. Int J Clin Oncol 23：314-320, 2018.

Norihiro Aibe, Kumiko Karasawa, Masahiko Aoki, Keiko Akahane, Yasuhiro Ogawa, Etsuyo Ogo, Shuichi Kanamori, Jiro Kawamori, Anneyuko I Saito, Kenshiro Shiraishi, Hiroshi Sekine, Seiji Tachiiri, Michiko Yoshimura and Chikako Yamaushi. Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer. Journal of Radiation Research, 2018, pp. 1-8 doi: 10.1093

Iwata H, Ishikawa H, Takagi M, Okimoto T, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Araya M, Mizoe JE, Gosho M, Nakamura K, Shirato H, Sakurai H. Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group. Cancer Med 2018 Feb 14. doi: 10.1002/cam4.1350.

Hiromitsu Iwata, Hitoshi Ishikawa, Masaru Takagi, Tomoaki Okimoto, Sigeyuki Murayama, Tetsuo Akimoto, Hitoshi Wada, Takeshi Arimura, Yoshitaka Sato, Masayuki Araya, Jun-etsu Mizoe, Masahiko Gosho, Katsumasa Nakamura, Hiroki Shirato & Hideyuki Sakurai. Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group. Cancer Medicine 2018; 7(3):677–689 doi: 10.1002/cam4.1350

Yamazaki T, Kodaira T, Ota Y, Akimoto T, Wada H, Hiratsuka J, Nishimura Y, Ishihara S, Nonoshita T, Hayakawa K, Sekii S, Uchida N.Retrospective analysis of definitive radiotherapy for neck node metastasis from unknown primary tumor: Japanese Radiation Oncology Study Group study.Jpn J Clin Oncol.47(9),856-862,2017.

Yamaguchi M, Suzuki R, Oguchi M, Asano N, Amaki J, Akiba T, Maeda T, Itasaka S, Kubota N, Saito Y, Kobayashi Y, Itami J, Ueda K, Miyazaki K, Ii N, Tomita N, Sekiguchi N, Takizawa J, Saito B, Murayama T, Ando T, Wada H, Hyo R, Ejima Y, Hasegawa M, Katayama N.Treatments and outcomes of patients with extranodal natural killer/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan.J Clin Oncol. 2017 Jan;35(1):32-39.

Tomoki Kimura, Yasushi Nagata, Hideyuki Harada, Shinya Hayashi, Yukinori Matsuo, Tsuyoshi Takanaka, Masaki Kokubo, Kenji Takayama, Hiroshi Onishi, Koichi Hirakawa, Yoshiyuki Shioyama, Takeshi Ehara Phase I study of stereotactic body radiation therapy for centrally located stage IA non‑small cell lung cancer (JROSG10-1) Int J Clin Oncol (2017) 22:849–856

Jingu K, Matsuo Y, Onishi H, Yamamoto T, Aoki M, Murakami Y, Yamashita H, Kakuhara H, Nemoto K, Sakayauchi T, Okamoto M, Niibe Y, Nagata Y, Ogawa K. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer. Anticancer Res. 2017 May;37(5):2709-2713.

Tomoko Itazawa, Yukihisa Tamaki, Takafumi Komiyama, Yasumasa Nishimura, Yuko Nakayama, Hiroyuki Ito, Yasuhisa Ohde, Masahiko Kusumoto, Shuji Sakai, Kenji Suzuki, Hirokazu Watanabe, Hisao Asamura. The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus- based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. Journal of Radiation Research, Vol. 58, No. 1, 2017, pp. 86-105

Yoshioka Y, Kotsuma T, Komiya A, Kariya S, Konishi K, Nonomura N, Ogawa K, Tanaka E, Nishimura K, Fujiuchi Y, Kitamura H, Yamagami T, Yamasaki I, Nishimura K, Teshima T, Nakamura K, Itami J. Nationwide multicenter retrospective study on high-dose-rate brachytherapy as monotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 97(5), 952–961, 2017.

Ishiyama H, Kamitani N, Kawamura H, Kato S, Aoki M, Kariya S, Matsumura T, Kaidu M, Yoshida K, Hashimoto Y, Noda Y, Lim KH, Kawase T, Takahashi T, Inaba K, Kumano M, Yoshikawa N, Yoshioka Y, Nakamura K, Hiratsuka J, Itami J, Hayakawa K. Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: an Asian Prostate HDR-BT Consortium Brachytherapy 2017 16(3):503-510. doi: 10.1016/j.brachy.2017.01.006.

Tatsuya Ohno, Masaru Wakatsuki, Takafumi Toita, Yuko Kaneyasu, Ken Yoshida, Shingo Kato, Noriko Ii, Sunao Tokumaru, Hitoshi Ikushima, Takashi Uno, Shin-ei Noda, Tomoko Kazumoto and Yoko Harima, the Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG): Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients. Journal of Radiation Research, 2016, pp. 1-10 doi: 10.1093

Naoto Shikama, Kenji Sekiguchi, Naoki Nakamura, Hiroshi Sekine, Yuko Nakayama, Kazufumi Imanaka, Takeshi Akiba MD, Masahiko Aoki, Yoshiomi Hatayama, Etsuyo Ogo, Yoshikazu Kagami, Miho Kawashima, Kumiko Karasawa. Final results from a multi-center prospective study (JROSG 05-5) on postoperative radiotherapy for patients with ductal carcinoma in-situ with involved surgical margin or close margin widths of 1 mm or less. Journal of Radiation Research, 2015, pp1-5.

Nishimura Y, Jingu K, Itasaka S, Negoro Y, Murakami Y, Karasawa K, Kawaguchi G, Isohashi F, Kobayashi M, Itoh Y, Ariga T.Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG). Int J Clin Oncol. 2016 Feb;21(1):88-94.

Hidefumi Aoyama, MD, PhD; Masao Tago, MD, PhD; Hiroki Shirato, MD, PhD; et al. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. JAMA Oncol. Published online May 14, 2015. doi:10.1001/jamaoncol.2015.1145
＊Research Selected for ASCO’s Clinical Cancer Advances 2016

Tomoki Kimura, Yasushi Nagata, Hideyuki Harada, Shinya Hayashi, Yukinori Matsuo Tsuyoshi Takanaka, Masaki Kokubo, Kenji Takayama, Hiroshi Onishi, Koichi Hirakawa, Yoshiyuki Shioyama, Takeshi Ehara. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). Int J Clin Oncol, Vol.21 No. 3 June 2016.

Kosugi T, Shikama N, Saito T, Nakamura N, Nakura A, Harada H, Wada H, Nozaki M, Uchida N, Nakamura K. A Nationwide Survey in Japan of Palliative Radiotherapy for Bleeding in Gastrointestinal and Genitourinary Tumor Patients. World J Oncol. 2016; 7(2-3): 29-3.

Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M, Shaw P, Beyene J, Chang EL. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):710-7. doi: 10.1016/j.ijrobp.2014.10.024.

Maebayashi T, Ishikawa H, Yorozu A, Yoshida D, Katoh H, Nemoto K, Ishihara S, Takemoto S, Ishibashi N, Tokumaru S, Akimoto T; Working Subgroup of Urological Cancers in Japanese　Patterns of practice in the radiation therapy for bladder cancer: survey of the Japanese Radiation Oncology Study Group (JROSG). Radiation Oncology Study Group.　Jpn J Clin Oncol. 2014 44(11):1109-15

Ariga T, Toita T, Kato S, Kazumoto T, Kubozono M, Tokumaru S, Eto H, Nishimura T, Niibe Y, Nakata K, Kaneyasu Y, Nonoshita T, Uno T, Ohno T, Iwata H, Harima Y, Wada H, Yoshida K, Gomi H, Numasaki H, Teshima T, Yamada S, Nakano T.Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study.J Radiat Res. 2015;56(5):841-8.

Aoki M, Mizowaki T, Akimoto T, Nakamura K, Ejima Y, Jingu K, Tamai Y, Nakajima N, Takemoto S, Kokubo M, Katoh H.Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG.　J Radiat Res. 2014 55(3):533-40

悪性リンパ腫に対する放射線治療の新しい動き　ISRTを中心に小口 正彦, 長谷川 正俊, 石橋 直也, 磯部 公一, 今井 美智子, 江島 泰生, 糟谷 健夫, 片山 絵美子, 笹井 啓資, 副島 俊典, 早渕 尚文 臨床血液 (0485-1439)55巻10号 Page1903-1911(2014.10)

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y, the Japanese Radiation Oncology Study Group (JROSG). Factors influencing survival outcome for radiotherapy for biliary tract cancer: A multicenter retrospective study. Radiother Oncol 2014;110:546-52

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y, and the Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: A propensity-score matched-pair analysis. Int J Radiat Oncol Biol Phys 2014;89:822-9

Naoto Shikama, Kenji Sekiguchi, Naoki Nakamura, Hiroshi Sekine, Yuko Nakayama, Kazufumi Imanaka, Takeshi Akiba, Masahiko Aoki, Yoshiomi Hatayama, Etsuko Ogo, Yoshikazu Kagami,Miho Kawashima, and Kumiko Karasawa. Preliminary Results from a Multi-center Prospective Study (JROSG 05-5) on Postoperative Radiotherapy for Patients with High-risk Ductal Carcinoma in situ with Involved Margins or Margin Widths 1 mm or less than. Columbia International Publishing American Journal of Breast Cancer Research (2014) Vol. 1 No. 1 pp. 1-8

Nakamura N, Shikama N, Wada H, Harada H, Nozaki M, Nagakura H, Tago M, Oguchi M, Uchida N.Variability in the point to which single direct field irradiation is prescribed for spinal bone metastases: a survey of practice patterns in Japan.　J Radiat Res. 2013 1;54(6):1065-8

Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y; Japanese Radiation Oncology study Group (JROSG).Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.　Radiat Oncol. 2013 Apr 1;8:76

Fumiaki Isohashi, Kazuhiko Ogawa, Hirobumi Oikawa, Hiroshi Onishi, Nobue Uchida, Toshiya Maebayashi,Naoto Kanesaka, Tetsuro Tamamoto, Hirofumi Asakura, Takashi Kosugi, Takashi Uno, Yoshinori Ito,Katsuyuki Karasawa, Makoto Takayama, Yoshihiko Manabe, Hideya Yamazaki, Mitsuhiro Takemoto,Yasuo Yoshioka, Kenji Nemoto, Yasumasa Nishimura on behalf of the Japanese Radiation Oncology study Group (JROSG)　Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiation Oncology　8: 76-85,2013.

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (‹4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 2012; 82: e49-56.

鹿間直人　多施設共同大規模データベースの意義JROSG(Japanese Radiation Oncology Group) 05-5試験の意義.乳癌（第２版）基礎と臨床の最新研究動向（日本臨床）2012; 70:773-76

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 2012;82(1):e49-56.

Tokumaru S, Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai H, Teshima T, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N, Kudo S.Insufficiency Fractures After Pelvic Radiation Therapy for Uterine Cervical Cancer: An Analysis of Subjects in a Prospective Multi-institutional Trial, and Cooperative Study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). Int J Radiat Oncol Biol Phys　84(2)： e195-200, 2012.

Nakamura N, Shikama N, Wada H, Harada H, Nozaki M, Nagakura H, Tago M, Oguchi M, Uchida N; Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy. Pattern of practice in palliative radiotherapy for painful bone metastases: a survey in Japan. Int J Radiat Oncol Biol Phys　83(1)： e117-120, 2012.

Nishimura Y, Hiraoka M, Koike R, Nakamatsu K, Itasaka S, Kawamura M, Negoro Y, Araki N, Ishikawa H, Fujii T, Mitsuhashi N.Long-term follow-up of a randomized phase II study of cisplatin/5-Fu concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021).Jpn J Clin Oncol 42(9): 807-812, 2012.

Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H,Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancers. Concurrent radiotherapy and Gemcitabine for unresectable pancreatic adenocarcinoma: Impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys 83(2): 559-565, 2012.

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (‹4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys 82(1): e49-56, 2012.

Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Clin Oncol 17(1): 48-54, 2011.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y： Intraoperative radiotherapy for unresectable pancreatic cancer： a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 80(1): 111-118, 2011.

三橋　紀夫：特定非営利法人日本放射線腫瘍学機構 (Radiation Oncology Study Group: JROSG) の活動～多施設共同臨床試験を中心に～．映像情報メディカル42(12): 1042-1046, 2010.

Ogawa K, Shibuya H, Uchida N, Onishi H, Okuno Y, Myojin M, Kobayashi M, Ogawa Y, Kanesaka N, Shibuya K, Tokumaru S, Sasamoto R, Karasawa K, Nemoto K, Nishimura Y： Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma： impact of chemotherapy on local control and survival. Anticancer Res 30(7)： 2959-2967, 2010.

Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K, Nishimura Y： Pattern of radiotherapy practice for pancreatic cancer in Japan： results of the Japanese Radiation Oncology Study Group (JROSG) survey. Int J Radiat Oncol Biol Phys 77(3): 740-750, 2010.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y： Intraoperative radiotherapy for resected pancreatic cancer： a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys　77(3): 743-742, 2010.

Sakayauchi T, Nemoto K, Ishioka C, Onishi H, Yamamoto M, Kazumoto T, Makino M, Yonekura R, Itami J, Sasaki S, Suzuki G, Hayabuchi N, Tamamura H, Onimaru R, Tamamoto T, Yamada S. Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancer. Jpn J Radiol 27(3)：131-137, 2009.

Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kodaira T, Kazumoto T, Kataoka M, Shikama N, Kenjo M, Teshima T, Kagami Y. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer： the individual case review. Jpn J Clin Oncol 39(12)： 813-819, 2009.

Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Negoro Y, Fujiwara K, Sakurai H, Mitsuhashi M. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer： Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021) Radiotherapy and Oncolog. 92(2): 260-265, 2009.

Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T; Japan Radiation Oncology Study Group.： Results of concomtant chemoradiotherapy for cervical cancer using high dose rate intracavitary brachetherapy： study of JROSG (Japan Radiation Oncology Study Group). Acta Oncol 47(3)： 434-441, 2008.

Nakamura K, Mizowaki T, Imada H, Karasawa K, Uno T, Onishi H, Nihei K, Sasaki S, Ogura M, Akimoto T.： External-beam radiotherapy for localized or locally advanced prostate cancer in Japan： a multi-institutional outcome analysis. Jpn J Clin Oncol 38(3)： 200-204, 2008.

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Matsuno Y, Oguchi M.; A Multicenter Phase II Study of Local Radiation Therapy for Stage IEA Mucosa-Associated Lymphoid Tissue Lymphomas： A Preliminary Report from the Japan Radiation Oncology Group (Jarog). Int J Radiat Oncol Biol Phys 69(4): 1181-1186, 2007.

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Oguchi M.; Initial Experience with the Quality Assurance Program of Radiation Therapy on behalf of Japan Radiation Oncology Group (JAROG). Jpn J Clin Oncol 37(2): 135-139, 2007.

Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5): 1388-1395, 2007.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M; Oya O, Hirota S; Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases： a randomized controlled trial. JAMA 295(21)： 2483-2491, 2006.

Karasawa K, Mitsumori M, Yamauchi C, Gomi K, Kataoka M, Uematsu T, Kodaira T, Yamakawa M, Karasawa K, Watanabe T, Tsujino K, Hiraoka M.： Treatment outcome of breast-conserving therapy in patients with positive or close resection margins： Japanese multi-institutional survey for radiation dose effect. Breast Cancer 12(2)： 91-98, 2005.

癌の臨床 Vol.56 No.7 2010.7　特集
JROSG（Japanese Radiation Oncology Study Group）の現状

■脳・中枢神経腫瘍委員会p489-492
芝本　雄太　前林　勝也

■頭頚部腫瘍委員会p493-498
中村　達也　古平　毅　茂松　直之　寺原　敦朗　山崎　拓也　不破信和　兼平　千裕

■消化器腫瘍委員会p499-504
西村　恭昌　小川　和彦

■肺・縦隔腫瘍委員会p505-510
永田　靖　木村　智樹

■乳腺腫瘍委員会p511-516
唐澤　久美子　鹿間　直人

■婦人科腫瘍委員会p517-524
中野　隆史　戸板　孝文　徳丸　直郎　大野　達也　坂田　耕一　加藤　真吾　宇野　隆　清原　浩樹　新部　譲　田中　英一　楮本　智子　兼安　祐子　西村　哲夫　五味　弘道　高橋　健夫　播磨　洋子

■泌尿器腫瘍委員会p525-530
秋元　哲夫　中村　和正　溝脇　尚志　萬　篤憲　加藤　弘之　小塚　拓洋　前林　俊也　青木　学　幡野　貴志　石川　仁　平塚　純一

■悪性リンパ腫・血液腫瘍委員会p531-536
小口　正彦　長谷川　正俊　磯部　公一　笹井　啓資　今井　美智子　江島　泰生　齋藤　淳一

■小児腫瘍委員会p 537-544
正木　英一

■緩和医療委員会p545-550
鹿間　直人